메뉴 건너뛰기




Volumn 17, Issue 20, 2011, Pages 2558-2562

Proteasome inhibitor treatment in alcoholic liver disease

Author keywords

Alcoholic liver disease; Glutathione; Oxidative stress; Proteasome inhibitor treatment; Steatosis

Indexed keywords

ALPHA TOCOPHEROL; BORTEZOMIB; CYTOCHROME P450 2E1; ETANERCEPT; FREE RADICAL; GLUTATHIONE PEROXIDASE 2; GLUTATHIONE REDUCTASE; GLUTATHIONE SYNTHASE; INFLIXIMAB; MANGANESE SUPEROXIDE DISMUTASE; PENTOXIFYLLINE; PROTEASOME; PROTEASOME INHIBITOR; REACTIVE OXYGEN METABOLITE; UBIQUITIN;

EID: 79957801753     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i20.2558     Document Type: Article
Times cited : (12)

References (52)
  • 1
    • 40749159213 scopus 로고    scopus 로고
    • Quantifying the risk for alcohol-use and alcoholattributable health disorders: Present findings and future research needs
    • Li TK. Quantifying the risk for alcohol-use and alcoholattributable health disorders: present findings and future research needs. J Gastroenterol Hepatol 2008; 23 Suppl 1: S2-S8
    • (2008) J Gastroenterol Hepatol , vol.23 , Issue.SUPPL. 1.
    • Li, T.K.1
  • 4
    • 33745755554 scopus 로고    scopus 로고
    • Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: Role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production
    • Thakur V, Pritchard MT, McMullen MR, Wang Q, Nagy LE. Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production. J Leukoc Biol 2006; 79: 1348-1356
    • (2006) J Leukoc Biol , vol.79 , pp. 1348-1356
    • Thakur, V.1    Pritchard, M.T.2    McMullen, M.R.3    Wang, Q.4    Nagy, L.E.5
  • 6
    • 0036139102 scopus 로고    scopus 로고
    • Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species
    • Nieto N, Friedman SL, Cederbaum AI. Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Hepatology 2002; 35: 62-73
    • (2002) Hepatology , vol.35 , pp. 62-73
    • Nieto, N.1    Friedman, S.L.2    Cederbaum, A.I.3
  • 7
    • 0034615999 scopus 로고    scopus 로고
    • p-hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima
    • Heller JI, Crowley JR, Hazen SL, Salvay DM, Wagner P, Pennathur S, Heinecke JW. p-hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima. J Biol Chem 2000; 275: 9957-9962
    • (2000) J Biol Chem , vol.275 , pp. 9957-9962
    • Heller, J.I.1    Crowley, J.R.2    Hazen, S.L.3    Salvay, D.M.4    Wagner, P.5    Pennathur, S.6    Heinecke, J.W.7
  • 8
    • 3042802690 scopus 로고    scopus 로고
    • Glutathione: An overview of biosynthesis and modulation
    • Anderson ME. Glutathione: an overview of biosynthesis and modulation. Chem Biol Interact 1998; 111-112: 1-14
    • (1998) Chem Biol Interact , vol.111-112 , pp. 1-14
    • Anderson, M.E.1
  • 9
    • 0034955787 scopus 로고    scopus 로고
    • Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes
    • Hammond CL, Lee TK, Ballatori N. Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes. J Hepatol 2001; 34: 946-954
    • (2001) J Hepatol , vol.34 , pp. 946-954
    • Hammond, C.L.1    Lee, T.K.2    Ballatori, N.3
  • 10
    • 0344393732 scopus 로고    scopus 로고
    • Strategies for reversing drug resistance
    • Fojo T, Bates S. Strategies for reversing drug resistance. Oncogene 2003; 22: 7512-7523
    • (2003) Oncogene , vol.22 , pp. 7512-7523
    • Fojo, T.1    Bates, S.2
  • 11
    • 27744540258 scopus 로고    scopus 로고
    • Marked differences in the efficacy of post-insult gene therapy with catalase versus glutathione peroxidase
    • Chang P, Cheng E, Brooke S, Sapolsky R. Marked differences in the efficacy of post-insult gene therapy with catalase versus glutathione peroxidase. Brain Res 2005; 1063: 27-31
    • (2005) Brain Res , vol.1063 , pp. 27-31
    • Chang, P.1    Cheng, E.2    Brooke, S.3    Sapolsky, R.4
  • 14
    • 0034465251 scopus 로고    scopus 로고
    • Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial
    • Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 1637-1648
    • (2000) Gastroenterology , vol.119 , pp. 1637-1648
    • Akriviadis, E.1    Botla, R.2    Briggs, W.3    Han, S.4    Reynolds, T.5    Shakil, O.6
  • 18
  • 19
    • 0025297895 scopus 로고
    • Disulfiram treatment of alcoholism
    • Wright C, Moore RD. Disulfiram treatment of alcoholism. Am J Med 1990; 88: 647-655
    • (1990) Am J Med , vol.88 , pp. 647-655
    • Wright, C.1    Moore, R.D.2
  • 20
    • 48149090212 scopus 로고    scopus 로고
    • The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor?
    • Cvek B, Dvorak Z. The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor? Drug Discov Today 2008; 13: 716-722
    • (2008) Drug Discov Today , vol.13 , pp. 716-722
    • Cvek, B.1    Dvorak, Z.2
  • 22
  • 23
    • 9644289334 scopus 로고    scopus 로고
    • The proteasome and MHC class I antigen processing
    • Kloetzel PM. The proteasome and MHC class I antigen processing. Biochim Biophys Acta 2004; 1695: 225-233
    • (2004) Biochim Biophys Acta , vol.1695 , pp. 225-233
    • Kloetzel, P.M.1
  • 25
    • 61449206184 scopus 로고    scopus 로고
    • The persisting challenge of selective and specific proteasome inhibition
    • Groll M, Huber R, Moroder L. The persisting challenge of selective and specific proteasome inhibition. J Pept Sci 2009; 15: 58-66
    • (2009) J Pept Sci , vol.15 , pp. 58-66
    • Groll, M.1    Huber, R.2    Moroder, L.3
  • 26
    • 60749114007 scopus 로고    scopus 로고
    • Proteasome inhibition: A promising strategy for treating cancer, but what about neurotoxicity?
    • Gilardini A, Marmiroli P, Cavaletti G. Proteasome inhibition: a promising strategy for treating cancer, but what about neurotoxicity? Curr Med Chem 2008; 15: 3025-3035
    • (2008) Curr Med Chem , vol.15 , pp. 3025-3035
    • Gilardini, A.1    Marmiroli, P.2    Cavaletti, G.3
  • 27
    • 54249154594 scopus 로고    scopus 로고
    • Targeting the UPS as therapy in multiple myeloma
    • Chauhan D, Bianchi G, Anderson KC. Targeting the UPS as therapy in multiple myeloma. BMC Biochem 2008; 9 Suppl 1: S1
    • (2008) BMC Biochem , vol.9 , Issue.SUPPL. 1.
    • Chauhan, D.1    Bianchi, G.2    Anderson, K.C.3
  • 29
    • 0346692671 scopus 로고    scopus 로고
    • Bortezomib (millennium pharmaceuticals
    • Dou QP, Goldfarb RH. Bortezomib (millennium pharmaceuticals). IDrugs 2002; 5: 828-834
    • (2002) IDrugs , vol.5 , pp. 828-883
    • Dou, Q.P.1    Goldfarb, R.H.2
  • 32
    • 4644248931 scopus 로고    scopus 로고
    • Phase II study study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors
    • Shah MH, Young D, Kindler HL, Webb I, Kleiber B, Wright J, Grever M. Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors. Clin Cancer Res 2004; 10: 6111-6118
    • (2004) Clin Cancer Res , vol.10 , pp. 6111-6118
    • Shah, M.H.1    Young, D.2    Kindler, H.L.3    Webb, I.4    Kleiber, B.5    Wright, J.6    Grever, M.7    Phase, I.I.8
  • 34
    • 33646058316 scopus 로고    scopus 로고
    • Intracellular distribution of oxidized proteins and proteasome in HT22 cells during oxidative stress
    • Jung T, Engels M, Kaiser B, Poppek D, Grune T. Intracellular distribution of oxidized proteins and proteasome in HT22 cells during oxidative stress. Free Radic Biol Med 2006; 40: 1303-1312
    • (2006) Free Radic Biol Med , vol.40 , pp. 1303-1312
    • Jung, T.1    Engels, M.2    Kaiser, B.3    Poppek, D.4    Grune, T.5
  • 35
    • 35848935847 scopus 로고    scopus 로고
    • Regulation of ubiquitinproteasome system mediated degradation by cytosolic stress
    • Kelly SM, Vanslyke JK, Musil LS. Regulation of ubiquitinproteasome system mediated degradation by cytosolic stress. Mol Biol Cell 2007; 18: 4279-4291
    • (2007) Mol Biol Cell , vol.18 , pp. 4279-4291
    • Kelly, S.M.1    Vanslyke, J.K.2    Musil, L.S.3
  • 36
    • 33947517977 scopus 로고    scopus 로고
    • Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: Relevance to Parkinson disease
    • Yamamoto N, Sawada H, Izumi Y, Kume T, Katsuki H, Shimohama S, Akaike A. Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: relevance to Parkinson disease. J Biol Chem 2007; 282: 4364-4372
    • (2007) J Biol Chem , vol.282 , pp. 4364-4372
    • Yamamoto, N.1    Sawada, H.2    Izumi, Y.3    Kume, T.4    Katsuki, H.5    Shimohama, S.6    Akaike, A.7
  • 37
    • 33746809848 scopus 로고    scopus 로고
    • Neuroprotection with the proteasome inhibitor MLN519 in focal ischemic brain injury: Relation to nuclear factor kappaB (NF-kappaB), inflammatory gene expression, and leukocyte infiltration
    • Williams AJ, Dave JR, Tortella FC. Neuroprotection with the proteasome inhibitor MLN519 in focal ischemic brain injury: relation to nuclear factor kappaB (NF-kappaB), inflammatory gene expression, and leukocyte infiltration. Neurochem Int 2006; 49: 106-112
    • (2006) Neurochem Int , vol.49 , pp. 106-112
    • Williams, A.J.1    Dave, J.R.2    Tortella, F.C.3
  • 41
    • 0035138847 scopus 로고    scopus 로고
    • Intragastric ethanol infusion model for cellular and molecular studies of alcoholic liver disease
    • French SW. Intragastric ethanol infusion model for cellular and molecular studies of alcoholic liver disease. J Biomed Sci 2001; 8: 20-27
    • (2001) J Biomed Sci , vol.8 , pp. 20-27
    • French, S.W.1
  • 45
    • 65649100057 scopus 로고    scopus 로고
    • Epigenetics of proteasome inhibition in the liver of rats fed ethanol chronically
    • Oliva J, Dedes J, Li J, French SW, Bardag-Gorce F. Epigenetics of proteasome inhibition in the liver of rats fed ethanol chronically. World J Gastroenterol 2009; 15: 705-712
    • (2009) World J Gastroenterol , vol.15 , pp. 705-712
    • Oliva, J.1    Dedes, J.2    Li, J.3    French, S.W.4    Bardag-Gorce, F.5
  • 46
    • 53249091920 scopus 로고    scopus 로고
    • Diallyl trisulfide (DATS) effectively attenuated oxidative stressmediated liver injury and hepatic mitochondrial dysfunction in acute ethanol-exposed mice
    • Zeng T, Zhang CL, Zhu ZP, Yu LH, Zhao XL, Xie KQ. Diallyl trisulfide (DATS) effectively attenuated oxidative stressmediated liver injury and hepatic mitochondrial dysfunction in acute ethanol-exposed mice. Toxicology 2008; 252: 86-91
    • (2008) Toxicology , vol.252 , pp. 86-91
    • Zeng, T.1    Zhang, C.L.2    Zhu, Z.P.3    Yu, L.H.4    Zhao, X.L.5    Xie, K.Q.6
  • 47
    • 34250824010 scopus 로고    scopus 로고
    • Alcohol-induced oxidative stress
    • Das SK, Vasudevan DM. Alcohol-induced oxidative stress. Life Sci 2007; 81: 177-187
    • (2007) Life Sci , vol.81 , pp. 177-187
    • Das, S.K.1    Vasudevan, D.M.2
  • 48
    • 78650710068 scopus 로고    scopus 로고
    • Proteasome inhibitor up regulates liver antioxidative en-zymes in rat model of alcoholic liver disease
    • Bardag-Gorce F, Oliva J, Lin A, Li J, French BA, French SW. Proteasome inhibitor up regulates liver antioxidative en-zymes in rat model of alcoholic liver disease. Exp Mol Pathol 2011; 90: 123-130
    • (2011) Exp Mol Pathol , vol.90 , pp. 123-130
    • Bardag-Gorce, F.1    Oliva, J.2    Lin, A.3    Li, J.4    French, B.A.5    French, S.W.6
  • 49
    • 33745227748 scopus 로고    scopus 로고
    • Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cells
    • Meiners S, Ludwig A, Lorenz M, Dreger H, Baumann G, Stangl V, Stangl K. Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cells. Free Radic Biol Med 2006; 40: 2232-2241
    • (2006) Free Radic Biol Med , vol.40 , pp. 2232-2241
    • Meiners, S.1    Ludwig, A.2    Lorenz, M.3    Dreger, H.4    Baumann, G.5    Stangl, V.6    Stangl, K.7
  • 52
    • 79957818100 scopus 로고    scopus 로고
    • The beneficial effects of proteasome inhibitor treatment in alcoholic liver disease
    • Bardag-Gorce F, Oliva J, Li A, Li J, French SW. The beneficial effects of proteasome inhibitor treatment in alcoholic liver disease. FASEB J 2011; 25: 366.9
    • (2011) FASEB J , vol.25 , Issue.366 , pp. 9
    • Bardag-Gorce, F.1    Oliva, J.2    Li, A.3    Li, J.4    French, S.W.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.